Line 79: |
Line 79: |
| There is an array of laboratory tests available for the diagnosis of bluetongue, and the table below published by DEFRA<sup>1</sup> summarises these: | | There is an array of laboratory tests available for the diagnosis of bluetongue, and the table below published by DEFRA<sup>1</sup> summarises these: |
| | | |
− | <align="center">
| + | |
− | {| class="wikitable collapsible" | + | {| class="wikitable collapsible" width="75%" |
| | <center> <u> '''Test''' </u> </center> | | | <center> <u> '''Test''' </u> </center> |
| | <center><u>'''Specimen Required'''</u> </center> | | | <center><u>'''Specimen Required'''</u> </center> |
Line 86: |
Line 86: |
| |<center><u>'''Timescale'''</u> </center> | | |<center><u>'''Timescale'''</u> </center> |
| |- | | |- |
− | |'''Virus Isolation''' | + | |<u>'''Virus Isolation'''</u> |
| |Whole EDTA blood | | |Whole EDTA blood |
| |Virus | | |Virus |
| |1 - 3 weeks | | |1 - 3 weeks |
| |- | | |- |
− | |'''Antigen Detection''' <BR>Sandwich ELISA <BR>PCR <BR>Serum Neutralisation | + | |<U>'''Antigen Detection'''</U> <BR>Sandwich ELISA <BR>PCR <BR>Serum Neutralisation |
| |<BR>Whole heparin or EDTA blood; tissues <BR>Whole EDTA blood; tissues <BR>Whole heparin or EDTA blood; tissues | | |<BR>Whole heparin or EDTA blood; tissues <BR>Whole EDTA blood; tissues <BR>Whole heparin or EDTA blood; tissues |
| |<BR>Antigen - group specific <BR>Viral RNA - group specific<BR>Serotype | | |<BR>Antigen - group specific <BR>Viral RNA - group specific<BR>Serotype |
| |<BR>Blood: 5 - 14 days; Tissues: 4 hours <BR>2 days <BR>2 - 4 weeks | | |<BR>Blood: 5 - 14 days; Tissues: 4 hours <BR>2 days <BR>2 - 4 weeks |
| |- | | |- |
− | |'''Antibody Detection''' <BR> Competition ELISA <BR> Serum Neutralisation <BR> Pathogenicity Testing in Sheep | + | |<U>'''Antibody Detection'''</U> <BR> Competition ELISA <BR> Serum Neutralisation <BR> Pathogenicity Testing in Sheep |
| |<BR>Serum <BR>Serum <BR> Virus isolate | | |<BR>Serum <BR>Serum <BR> Virus isolate |
| |<BR>Antibody - group specific <BR>Antibody - serotype specific <BR>Virulence | | |<BR>Antibody - group specific <BR>Antibody - serotype specific <BR>Virulence |
Line 102: |
Line 102: |
| |- | | |- |
| |} | | |} |
− | </align>
| |
| | | |
| ===Pathology=== | | ===Pathology=== |